COVAX announces new agreement, plans for first deliveries

COVAX announces new agreement, plans for first deliveries
COVAX announced the signing of an advance purchase agreement for up to 40 million doses of the Pfizer-BioNTech vaccine; rollout to commence with successful execution of supply agreements. Additionally, COVAX announced that, pending WHO emergency use listings, nearly 150 million doses of the AstraZeneca/Oxford candidate are anticipated to be available in Q1 2021, via existing agreements with the Serum Institute of India (SII) and AstraZeneca. COVAX is therefore on track to deliver at least...

Comments

Popular posts from this blog

The world's longest indoor test track for self-driving vehicles

Spar Uttoxeter sold to experienced forecourt operator through Christie & Co

Advanced AI solution to meet retailers’ critical need for smarter merchandising